Genstar Capital Makes Majority Investment in Flourish Research

In The News
September 18, 2024

Ropes & Gray represented Genstar Capital in its majority investment in Flourish Research, an NMS Capital portfolio company and leading multi-site clinical trial organization focused on cardiovascular, metabolic, neuroscience, and infectious disease therapeutic areas. The announcement was made in a Sept. 18 press release. Terms of the transaction were not disclosed.

Based in San Francisco, Genstar Capital is a leading private equity firm that has been investing in companies for over 30 years. Genstar currently has approximately $49 billion of assets under management and targets investments focused on targeted segments of the financial services, industrials, software, and healthcare industries.

This team included private equity partners Chau Le and Elizabeth Gallucci, tax partner Leo Arnaboldi, health care partner David Peloquin, executive compensation & employee benefits partner Kyle Higley, employment partner Megan Bisk, finance partner Mike Lee, private equity counsel Amy Olson, strategic transactions counsel Emily Karlberg, and private equity associate Anna Park.